Answers are grounded in this paper and cite their sources.
Reports tissue-biased metabolism in bamboo, suggesting pathways for natural product development.
Bamboo is widely valued as a fast-growing timber resource, but its medicinal and phytochemical potential remains underexplored. Chimonocalamus fimbriatus is a metabolically distinctive bamboo species with marked accumulation of phenylpropanoid- and glycoside-related compounds. Here, we present a chromosome-level, haplotype-resolved genome assembly of C. fimbriatus and integrate metabolomic, transcriptomic, and proteomic data to characterize tissue-biased metabolism. Metabolite profiling detected differential accumulation of several phenylpropanoid-related compounds across tissues, with verbascoside and selected related intermediates enriched mainly in branches and stems and showing a developmental decrease in older tissues. We identified partially tissue-enriched genes encoding candidate enzymes associated with phenylpropanoid-related metabolic variation. Proteomic analysis further supported the involvement of several corresponding proteins. Transcript-protein discordance further suggests multi-layered post-transcriptional or post-translational regulation. Furthermore, measurements of PAL activity provide evidence for inferring candidate regulatory nodes underlying the tissue-specific accumulation of verbascoside. The whole-genome duplication (WGD) event experienced by C. fimbriatus provides a genetic basis for its metabolic diversity. Together, these results establish genomic and multi-omics resources for studying specialized metabolism in C. fimbriatus and offer a foundation for the future development of bamboo-derived natural products.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: